Cardiac iron across different transfusion-dependent diseases. - Wikidata - awgldk - TriplyDB

Cardiac iron across different transfusion-dependent diseases.

Cardiac iron across different transfusion-dependent diseases.

http://www.wikidata.org/entity/Q33958560

about

Infiltrative Cardiomyopathies MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and Pitfalls Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study.Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.Iron overload cardiomyopathy: better understanding of an increasing disorder.How I treat Diamond-Blackfan anemia.Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood.Quantification of liver iron with MRI: state of the art and remaining challenges.Estimating tissue iron burden: current status and future prospects.An update on iron chelation therapy Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.Prooxidant mechanisms in iron overload cardiomyopathy.How early can myocardial iron overload occur in beta thalassemia major?Iron overload: consequences, assessment, and monitoring.Myelodysplastic Syndromes and Iron Chelation Therapy Assessment of the relationship between fragmented QRS and cardiac iron overload in patients with beta-thalassemia major.Iron overload in myelodysplastic syndromes: diagnosis and management.Current strategies for the management of children with sickle cell disease.Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.MRI of cardiac iron overload.Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant.Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.Iron chelation in thalassemia: time to reconsider our comfort zones.The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease.Efficacy and Safety of Deferasirox in Pediatric Patients of Thalassemia at a Tertiary Care Teaching Hospital The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.Comparison of myocardial and hepatic iron loading, assessed by MRI T2*, in patients with myelodysplastic syndromes, thalassaemia major and controls.Evaluation of myocardial and hepatic iron loading by MRI T2* in multi-transfused patients with repeated blood loss as compared to thalassaemia major patients and controls Cardiac iron overload in sickle-cell disease.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL project.A novel, nontoxic iron chelator, super-polyphenol, effectively induces apoptosis in human cancer cell lines Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation

P2860

Q26798533-DC91CC4D-5691-45A6-9C44-54993AB49340 Q28072173-FBDD3047-8696-4480-AB58-3F1AD4F33416 Q33647638-E0E3287D-14A9-447F-A852-0F998E9A39A0 Q33827300-3EBA22F8-BD8F-41AB-AA03-B8DCBD49E1D9 Q34165921-02C9EE85-76B4-4B71-A085-641EF8D187D0 Q34310852-02F8568E-CB2A-45B8-B213-82AD7FC2E1BA Q34508200-66ACC9EC-76A4-452C-BA80-F376CEB76ED4 Q35020698-7267F672-224B-4E81-91BC-1DFD886C53C6 Q35793545-BBCEF932-D139-4288-A85B-75B67B47F39C Q36393446-F6465658-C848-42DB-A6F0-8BC721962966 Q36470425-EBD508D3-6612-4050-9C07-84F4A6648C14 Q37367573-9996E5DD-1BF6-40DD-8534-DD145E9309E7 Q37504957-B9EB116B-676E-4EC3-8BA7-9C745AB5B18E Q37650453-C751C67D-C287-4EE4-B421-9929E373B785 Q37677229-FEE01128-668B-4B36-BA9C-840CD369A345 Q37680605-CCDF3046-86B0-4EF2-BB60-C50990FD6A0C Q37686048-C609144F-4B2E-4424-90B4-76C7067F5DAA Q37810082-A1A3DB0D-2DA2-4683-BDB8-B570717A5264 Q37981248-D23517FB-9CA6-47F1-BEF9-9B184667713C Q38054638-FC68C7F4-0935-4A6F-B813-2AAA0DFD0493 Q38905476-D3EA629D-6FBA-488B-9EC8-5116BDBBC7E3 Q39045339-C6B4E4FF-684D-47D3-A3D2-FFD64296EDC6 Q39270177-FE7443CD-0371-4315-B4E7-10EA83D5B01B Q39300721-236FEB09-DEEE-4EEB-83F4-98A123E1004E Q39782885-8C92FCF3-0ED3-480F-92DD-0BCBD6CA1322 Q40787079-9F4DA080-8D71-4148-ABD5-F2CE40CBF77E Q41601748-CA2FB24E-43E5-492B-999C-5D89AFA86A47 Q41856578-BFCAFB9F-D13E-4348-85B8-5A2A50FE9010 Q41857841-6E305029-F9AE-4A54-B83F-5BC24FD5E187 Q41875301-21FFA285-62EA-4DEA-AC2A-33D6848DEAD7 Q42555133-2B5E6096-D08C-4C10-803F-0C21FD233783 Q42809780-A9E64FEF-8448-4B38-999B-396981411D1F Q46804573-55F5B9A0-8536-4705-AF65-99CE19EBE20E Q47799282-E15C40C3-6E0B-463A-AD13-36B4E920D331 Q48557800-FCB79785-A752-40D3-9BA3-08F9D7633D0C Q50231452-FB7E42D2-F2D9-432A-8AD3-1E64D7468231 Q51877530-D3E092AC-8924-489B-8E9F-A978B17513E4 Q58697719-8825D0E8-7091-414C-80CA-F1BE2F57944C Q59110232-9EB26111-85BB-4B08-9125-1DC0831BD23B

P2860

Cardiac iron across different transfusion-dependent diseases.

http://www.wikidata.org/entity/Q33958560

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cardiac iron across different transfusion-dependent diseases.

@ast

Cardiac iron across different transfusion-dependent diseases.

@en

type

label

Cardiac iron across different transfusion-dependent diseases.

@ast

Cardiac iron across different transfusion-dependent diseases.

@en

prefLabel

Cardiac iron across different transfusion-dependent diseases.

@ast

Cardiac iron across different transfusion-dependent diseases.

@en

P1433

Q33958560-6B039279-376F-41C4-B7FB-B16BB68C5B72

P1476

Q33958560-2801A1F2-B53D-45F8-92FA-5E03333F43BD

P2093

Q33958560-AC421796-C3E4-4AF4-91FD-F037698A351C

P2860

Q33958560-10838259-96D5-4438-8C23-0C9D8A3F7FA1

Q33958560-2AC5C662-AF8D-403E-8BBC-D3EB909E5D29

Q33958560-2B08E79E-D189-4C5F-81B3-6F0009695EEF

Q33958560-31F04709-B4B2-432D-8A31-C6D88D66574B

Q33958560-386B6C46-7F4A-46B0-85A2-C1F9F9467F3A

Q33958560-38ED5EE8-377E-4BEF-8C27-320A74CC873D

Q33958560-39991BC7-7F75-44DC-80C4-BFC8E2CCFA63

Q33958560-3A79D82E-3A8D-495B-A511-719FA19D0966

Q33958560-40E7C86B-43C0-4085-BFAC-074F34641389

Q33958560-411CCA51-CD22-4430-8187-A267A9DE594B

P304

Q33958560-4FB0C225-7845-4922-9A84-9CCF09C77967

P31

Q33958560-98E739FB-175A-4F57-B83A-1557F4D859B9

P356

Q33958560-211CF5A2-619C-4106-9CFC-7B3BA163CD4F

P478

Q33958560-FD586466-48DF-43CA-A661-3B864FC9D490

P577

Q33958560-85DDBC2F-3E1D-448A-8527-9B79C5980A20

P698

Q33958560-6331F4CC-04CD-44CB-A2AB-1FFD30E87AE3

P932

Q33958560-2CCFBC93-64C0-413B-B2B2-EC74C5F0798E

P356

S0268-960X(08)70004-3

P1433

P1476

Cardiac iron across different transfusion-dependent diseases.

@en

P2093

John C Wood

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences.

Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases

Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major

MRI detects myocardial iron in the human heart.

Physiology and pathophysiology of iron cardiomyopathy in thalassemia.

Diagnosis and management of transfusion iron overload: the role of imaging

Comparison of twice-daily vs once-daily deferasirox dosing in a gerbil model of iron cardiomyopathy.

Magnetic resonance imaging measurement of iron overload.

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

P304

S14-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0268-960X(08)70004-3

http://www.w3.org/2001/XMLSchema#string

P478

22 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19059052

http://www.w3.org/2001/XMLSchema#string

P932

2896332

http://www.w3.org/2001/XMLSchema#string